Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team (Q78066986)
Jump to navigation
Jump to search
scientific article published on 01 August 1999
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team |
scientific article published on 01 August 1999 |
Statements
Efficacy and safety of delavirdine mesylate with zidovudine and didanosine compared with two-drug combinations of these agents in persons with HIV disease with CD4 counts of 100 to 500 cells/mm3 (ACTG 261). ACTG 261 Team (English)
G H Friedland
R Pollard
B Griffith
M Hughes
G Morse
R Bassett
W Freimuth
L Demeter
E Connick
T Nevin
1 August 1999